Zachary Zubulake reports in PharmTech Explained that industry experts Brian Drapeau and Richard Jaenisch analyzed how AI is reshaping GMP workflows while regulators tighten scrutiny on its use in pharmaceutical manufacturing. The discussion highlights a shift in compliance expectations where
